Qube Research & Technologies LTD Reviva Pharmaceuticals Holdings, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.25 - $3.79 $26,828 - $81,344	-21,463 Reduced 99.77%	50 $0
Q1 2024 May 14, 2024	SELL	$2.76 - $5.52 $38,228 - $76,457	-13,851 Reduced 39.17%	21,513 $81,000
Q4 2023 Feb 13, 2024	BUY	$3.56 - $6.04 $115,123 - $195,321	32,338 Added 1068.67%	35,364 $182,000
Q3 2023 Nov 13, 2023	BUY	$3.91 - $5.9 $11,831 - $17,853	3,026 New	3,026 $14,000

9.97M

133K

43.9K

Ticker RVPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,442,900
Market Cap $26M
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.